Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
<strong>Background </strong>Around one million individuals in the UK have heart failure (HF), a chronic disease that causes significant morbidity and mortality. N-terminal pro–B-type natriuretic peptide (NT-proBNP) monitoring could help improve the care of patients with HF in the communi...
Main Authors: | Chami, J, Fleming, S, Taylor, C, Bankhead, C, James, T, Shine, B, McLellan, J, Hobbs, FDR, Perera, R |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Royal College of General Practitioners
2022
|
Similar Items
-
Point-of-care NT-proBNP monitoring for heart failure: observational feasibility study in primary care
by: Jason Chami, et al.
Published: (2022-09-01) -
BNP/NT-proBNP in pulmonary arterial hypertension: time for point-of-care testing?
by: Robert A. Lewis, et al.
Published: (2020-05-01) -
The integration of BNP and NT-proBNP into clinical medicine
by: Swiss Medical Weekly
Published: (2007-01-01) -
Towards Point-of-Care Heart Failure Diagnostic Platforms: BNP and NT-proBNP Biosensors
by: Hussein Alawieh, et al.
Published: (2019-11-01) -
Sendaway capillary NT-proBNP in pulmonary hypertension
by: Eleanor Morris, et al.
Published: (2024-03-01)